Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2013-08-14 17:41:55
Reporting Period:
Filing Date:
Accepted Time:
2013-08-14 17:41:55
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
884629 Actavis Inc. ACT Pharmaceutical Preparations (2834) 953872914
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1471459 M Charles Mayr Morris Corporate Center Iii
400 Interpace Parkway
Parsippany NJ 07054
Chief Communic Off-Global No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0033 Disposition 2013-08-12 4,820 $133.23 23,490 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended.